Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: Different stimuli for release before and after heart transplantation?

American Heart Journal

Volumn 137, Issue 3, 1999, Pages 549-554

  Galatius, Søren ^a,d   Wroblewski, Henrik ^a   Sørensen, Vibeke B ^a   Bie, Peter ^b   Parving, Hans Henrik ^c   Kastrup, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; VON WILLEBRAND FACTOR;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENDOTHELIUM LESION; FEMALE; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

EID: 0032975646     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70505-3     Document Type: Article

References (21)

1. Lindsay DC, Holdright RD, Clarke D, Anand IS, Wilson PW, Collins P. Endothelial control of lower limb blood flow in chronic heart heart failure. Br Heart J 1996;75:469-76.
2. Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kircenbaum JM, et al. Responses of coronary arteries of cardiac transplant patients to acethylcholine. J Clin Invest 1988;81:21-31.
3. Cavero PG, Krishnankutty S, Galli F, DeMarco T, Keith F, Chatterjee K. Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: influence of cyclosporine therapy. Am Heart J 1994;127:1581-7
4. Stehouwer CDA, Lambert J, Donker AJM, Van Hinsberg WM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34(1):55-68.
5. Blann AD, McCollum CN. Von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vase Surg 1994;8:10-5.
6. Salomone OA, Elliot PM, Calvino R, Holt D, Kaski JC. Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. J Am Coll Cardiol 1996;28:14-9.
7. Lerman A, Kubo SH, Tschumperlin LK, Burnett JCJ. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol 1992;20:849-53.
8. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JCJ. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
9. Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley CM, Cleland JGF. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J 1994;127:607-12.
10. Hunt BJ, Segal H, Yacoub M. Hemostatic changes in heart transplant recipient and their relationship to accelerated coronary sclerosis. Transplantation 1993;55:309-15.
11. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9.
12. Penny WF, Weinstein M, Salzman EW, Ware JA. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation 1991;83:1630-6.
13. Boneu B, Abbal M, Plaante J, Bierme R. Factor-VII complex and endothelial damage. Lancet 1975;1(7922):1430.
14. Emmeluth C, Bie P. Effect, release and disposal of endothelin-1 in conscious dogs. Acta Physiol Scand 1992;146:197-204.
15. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWF:Ag). Scand J Clin Lab Invest 1987;47:143-9.
16. Levin EB. Endothelins. New Engl J Med 1995;333,6:356-63.
17. Hiroe M, Hirata Y, Fujita N, Umezawa S, Ito H, Tsujino M, et al. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:1114-5.
18. Tsutamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 1994;23:1427-33.
19. Chen JW, Gall MA, Deckert M, Jensen JS, Parving HH. Increased concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ 1995;311:405-6.
20. Bunchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991;67:782-4.
21. Fogo A, Hellings SE, Inagami T, Kon V. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 1992;42:770-4.